FGETX
Price
$23.29
Change
-$0.37 (-1.56%)
Updated
Jun 13 closing price
Net Assets
144.94M
RNPHX
Price
$66.83
Change
-$0.80 (-1.18%)
Updated
Jun 13 closing price
Net Assets
150.58B
Interact to see
Advertisement

FGETX vs RNPHX

Header iconFGETX vs RNPHX Comparison
Open Charts FGETX vs RNPHXBanner chart's image
Fidelity Advisor Glbl Capital Apprec M
Price$23.29
Change-$0.37 (-1.56%)
VolumeN/A
Net Assets144.94M
American Funds New Perspective R5E
Price$66.83
Change-$0.80 (-1.18%)
VolumeN/A
Net Assets150.58B
FGETX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGETX vs. RNPHX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGETX is a Buy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 151B vs. FGETX (145M). RNPHX pays higher dividends than FGETX: RNPHX (0.70) vs FGETX (0.00). FGETX was incepted earlier than RNPHX: FGETX (27 years) vs RNPHX (10 years). FGETX (1.57) is less costly to investors than RNPHX (0.56). FGETX is a more actively managed with annual turnover of: 47.00 vs. RNPHX (24.00). FGETX has a lower initial minimum investment than RNPHX: FGETX (0) vs RNPHX (250). RNPHX annual gain was more profitable for investors over the last year : 9.06 vs. FGETX (-0.09). RNPHX (48.85) and FGETX (47.97) have equivalent 5 years return.
FGETXRNPHXFGETX / RNPHX
Total Expense Ratio1.550.56277%
Annual Report Gross Expense Ratio1.570.56280%
Fund Existence27 years10 years-
Gain YTD1.5268.77317%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets145M151B0%
Annual Yield % from dividends0.000.70-
Returns for 1 year-0.099.06-1%
Returns for 3 years49.6843.45114%
Returns for 5 years47.9748.8598%
Returns for 10 years41.93N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HIW31.49-0.36
-1.13%
Highwoods Properties
SMMT19.78-0.38
-1.88%
Summit Therapeutics
CORZ11.89-0.25
-2.06%
Core Scientific
BDTX2.31-0.12
-4.94%
Black Diamond Therapeutics
LIDR0.78-0.08
-9.49%
AEye